Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Lancet study looked at 16 EU countries and the four nations of the UK as the NHS warns ‘we can’t treat our way out of this ...
6h
News Medical on MSNStudy shows life expectancy stagnation in EuropeThe rise in human life expectancy has slowed down across Europe since 2011, according to research from the University of East Anglia and partners.
The rise in human life expectancy has slowed down across Europe since 2011, according to research involving the University of ...
Health experts warn of a rise in alcohol-related cancers in India, linking alcohol consumption to over 20 types of cancer, ...
The report detailed 12 questions that patients should discuss with their physician that can help protect the brain from ...
Life expectancy in England is rising more slowly than in the rest of Europe, according to a new Lancet study ...
Annie Cooper couldn't free her 5-year-old son, Thomas, from a hyperbaric chamber as flames engulfed him last month. Her ...
The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...
Who has the most kids in the world? Discover the astonishing story of a Russian woman who gave birth to 69 children, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results